Anti-PD-1 (pembrolizumab biosimilar) mAb
| Common Name |
MK-3475 |
|---|---|
| Buffer |
Preservative: 0.1% Procline 300 Constituents: 50% Glycerol; PBS, pH 7.4; 0.1% BSA |
| Guarantee | 12 months from date of dispatch |
| Catalog Number | BME100006 |
|---|---|
| Package | 50 μl $80.00 ; 100 μl $160.00 |
| Synonyms | PDCD1, PD1, CD279, SLEB2 |
| Host Species | Humanized |
| IgG type | IgG4 |
| Clonality | Monoclonal |
| Formulation | Liquid |
| Purification | Purified from cell culture supernatant by affinity chromatography |
| Reactivity | Human |
| Applications | ELISA, Flow Cyt |
| Recommended Dilutions | ELISA 1:5000-10000, Flow Cyt 1:100 |
| Storage | Store at -20°C (Avoid repeated freezing and thawing) |
| Usage | Research use only |
| Images |
Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human PD1, mFc-His tagged protein (PME100025) can bind Anti-PD-1 Neutralizing antibody in a linear range of 0.24-6.49 ng/ml.
Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human PD1(A) were surface stained with anti-PD1 neutralizing antibody 1μg/ml (pembrolizumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Datasheet | Download | COA | Download |
|---|---|---|---|
| MSDS | Download | ||
简体中文
English
